1. Home
  2. STGW vs AGIO Comparison

STGW vs AGIO Comparison

Compare STGW & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stagwell Inc.

STGW

Stagwell Inc.

HOLD

Current Price

$6.44

Market Cap

1.7B

Sector

N/A

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$28.29

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STGW
AGIO
Founded
1980
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2006
2013

Fundamental Metrics

Financial Performance
Metric
STGW
AGIO
Price
$6.44
$28.29
Analyst Decision
Strong Buy
Buy
Analyst Count
7
8
Target Price
$8.39
$38.88
AVG Volume (30 Days)
1.5M
686.7K
Earning Date
04-30-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,909,000,000.00
$43,011,000.00
Revenue This Year
$13.27
$76.75
Revenue Next Year
$4.07
$170.73
P/E Ratio
N/A
N/A
Revenue Growth
2.39
N/A
52 Week Low
$4.28
$22.24
52 Week High
$7.52
$46.00

Technical Indicators

Market Signals
Indicator
STGW
AGIO
Relative Strength Index (RSI) 47.74 49.15
Support Level $4.94 $26.75
Resistance Level $6.50 $29.49
Average True Range (ATR) 0.35 1.30
MACD 0.00 0.03
Stochastic Oscillator 31.60 44.13

Price Performance

Historical Comparison
STGW
AGIO

About STGW Stagwell Inc.

Stagwell Inc is a challenger network using AI to deliver marketing and advertising solutions to its clients. It operates in five reportable segments: Marketing Services, Digital Transformation, Media and Commerce, Communications, and The Marketing Cloud. Maximum revenue is generated from the Marketing Services segment, which offers social media solutions, designs breakthrough brand campaigns, and creates immersive experiential marketing programs and social engagement strategies, helping clients connect with audiences across digital platforms. The various brands operating under this segment include 72 and Sunny, Anomaly, NRG, Harris Insights, TEAM, and Movers & Shaker. Geographically, the company generates maximum revenue from the United States, followed by the UK and other countries.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: